AwardedSpainGoods€9,158,400
SUMINISTRO DEL MEDICAMENTO DE TERAPIA AVANZADA IDECABTAGEN VICLEUCEL
- Published
- Published 26 February 2025
Overview
Fundació de Gestió Sanitària de l'Hospital de la Santa Creu i Sant Pau procured the advanced therapy medicine idecabtagen vicleucel for hospital use. Bristol-Myers Squibb SAU was awarded the contract on 22 January 2025 for EUR 3,052,800.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €9,158,400
- Procedure
- Direct
- Published
- 26 February 2025
Various medicinal products
Award outcome
- Awarded value
- €3,052,800
- Award date
- 22 January 2025
- Contract period
- — → 22 January 2027
- BRISTOL-MYERS SQUIBB SAU
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
26 February 2025
Contracting authority
Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau.
Procuring entityBarcelona, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.